The biotech market in the United States is experiencing a significant surge in demand for Tirzepatide APIs. This potent medication, used to treat type 2 diabetes, has attracted considerable attention from both patients and medical practitioners. As a result, numerous firms have emerged as makers of Tirzepatide APIs in the USA. Well-known Tirzepa